Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „Participants“
Suchtreffer
Begriffe & Kennungen
Comirnaty · 4.8 · The most frequent adverse reactions in participants were pain at the injection site (> 40%), fatigue, headache
Eintrag öffnenComirnaty · 4.8 · The most frequent adverse reactions in participants were pain at the injection site (> 40%), fatigue, headache
Eintrag öffnenComirnaty · 4.8 · The most frequent adverse reactions in participants who received the 10 mcg 3-dose series were irritability (>
Eintrag öffnenComirnaty · 4.8 · The most frequent adverse reactions in participants who received the 10 mcg 3-dose series were irritability (>
Eintrag öffnenComirnaty · 4.8 · The most frequent adverse reactions in participants who received the 10 mcg 3-dose series were irritability (>
Eintrag öffnenComirnaty · 4.8 · The most frequent adverse reactions in participants who received the 10 mcg 3-dose series were irritability (>
Eintrag öffnenComirnaty · 4.8 · The overall safety profile of Comirnaty in participants 5 to 11 years of age was similar to that seen in parti
Eintrag öffnenComirnaty · 4.8 · The overall safety profile of Comirnaty in participants 5 to 11 years of age was similar to that seen in parti
Eintrag öffnenComirnaty · 4.8 · The overall safety profile of Comirnaty in participants 5 to 11 years of age was similar to that seen in parti
Eintrag öffnenComirnaty · 4.8 · The overall safety profile of Comirnaty in participants 5 to 11 years of age was similar to that seen in parti
Eintrag öffnenComirnaty · 4.8 · The overall safety profile of Comirnaty in participants 5 to 11 years of age was similar to that seen in parti
Eintrag öffnenComirnaty · 4.8 · The safety profile in 545 participants 16 years of age and older receiving Comirnaty, that were seropositive f
Eintrag öffnenComirnaty · 4.8 · The safety profile in 545 participants 16 years of age and older receiving Comirnaty, that were seropositive f
Eintrag öffnenComirnaty · 4.8 · The safety profile in 545 participants 16 years of age and older receiving Comirnaty, that were seropositive f
Eintrag öffnenComirnaty · 4.8 · The safety profile in 545 participants 16 years of age and older receiving Comirnaty, that were seropositive f
Eintrag öffnenComirnaty · 4.8 · The safety profile in 545 participants 16 years of age and older receiving Comirnaty, that were seropositive f
Eintrag öffnenEdurant · 4.8 · All ADRs were mild or moderate. ADRs reported in at least 2 participants, regardless of severity, were: decrea
Eintrag öffnenEdurant · 4.8 · All ADRs were mild or moderate. ADRs reported in at least 2 participants, regardless of severity, were: decrea
Eintrag öffnenEdurant · 4.8 · All ADRs were mild or moderate. ADRs reported in at least 2 participants, regardless of severity, were: vomiti
Eintrag öffnenEdurant · 4.8 · All ADRs were mild or moderate. ADRs reported in at least 2 participants, regardless of severity, were: vomiti
Eintrag öffnen